M
2.16
0.08 (3.85%)
| Previous Close | 2.08 |
| Open | 2.13 |
| Volume | 329,247 |
| Avg. Volume (3M) | 127,504 |
| Market Cap | 74,351,736 |
| Price / Book | 11.33 |
| 52 Weeks Range | |
| Earnings Date | 11 May 2023 |
| Diluted EPS (TTM) | -2.46 |
| Current Ratio (MRQ) | 0.290 |
| Operating Cash Flow (TTM) | -8.35 M |
| Levered Free Cash Flow (TTM) | -7.59 M |
| Return on Assets (TTM) | -111.90% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Bullish | Mixed |
| Biotechnology (Global) | Bullish | Mixed | |
| Stock | MiNK Therapeutics, Inc. | Mixed | Bullish |
AIStockmoo Score
-0.7
| Analyst Consensus | 2.0 |
| Insider Activity | -3.5 |
| Price Volatility | 0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.5 |
| Average | -0.70 |
|
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| % Held by Insiders | 74.40% |
| % Held by Institutions | 1.58% |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| RYAN BARBARA | - | 11.98 | -1,500 | -19,653 |
| Aggregate Net Quantity | -1,500 | |||
| Aggregate Net Value ($) | -19,653 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 11.98 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| RYAN BARBARA | Director | 10 Mar 2026 | Sell (-) | 1,300 | 13.51 | 17,563 |
| RYAN BARBARA | Director | 09 Mar 2026 | Sell (-) | 200 | 10.45 | 2,090 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |